Day 2, 11:00am – 11:30am – Empowering residential care staff to minimise sedative medication use: Dementia Training Australia’s Medication Management Consultancy service
Despite over two decades of research demonstrating that the practice is harmful, people living with dementia are frequently administered medications such as antipsychotics to alleviate responsive behaviours. Antipsychotic use is particularly prevalent in residential care, where approximately a quarter of residents are using these medications at any given time. Programs that most effectively reduce the potentially inappropriate use of antipsychotic and other sedative medications in this situation involve sustained, multifaceted, multidisciplinary approaches that include strategies of benchmarking, training and ongoing review. Whilst several such programs have been trialled in Australia in a research context, there has not been a nationally available sedative-reduction program.
Dementia Training Australia (DTA) is a federally- funded training organisation that develops and delivers dementia-specific training to the care workforce. Using an awareness-to-adherence knowledge translation framework, DTA aims to improve the quality of care provided to people living with dementia by promoting sustained practice change. One service offered by DTA is a medication management consultancy (MMC), which aims to ensure that sedative medications are used for responsive behaviours in accordance with best-practice guidelines, if they are used at all. Modelled on earlier research projects, DTA’s MMC uses a highly practical approach that leverages off existing external resources to promote the quality use of these medications.